Bleomycin-induced mutation and recombination in Saccharomyces cerevisiae

Area of Science:

• Eukaryotic genetics
• Chemical mutagenesis
• Antitumor drug research

Background:

• Bleomycins (BM) are antitumor antibiotics.
• Understanding the genotoxicity of BM is crucial for clinical applications.

Purpose of the Study:

• To assess the recombinogenicity and mutagenicity of clinical bleomycin preparations.
• To investigate bleomycin's effects on genetic loci in Saccharomyces cerevisiae.

Main Methods:

• Testing bleomycin on Saccharomyces cerevisiae at high survival levels.
• Assaying over a dozen genetic loci for bleomycin-induced mutation or recombination.
• Treating both stationary and growing yeast cells with bleomycin.

Main Results:

• Bleomycin demonstrated mild to very high recombinogenicity and mutagenicity in yeast.
• The extent of bleomycin-induced genetic alterations varied by specific genetic markers.
• Potent recombinogenicity was observed in growing yeast cells.

Conclusions:

• Bleomycin induces genetic mutations and recombination in Saccharomyces cerevisiae.
• The genotoxic effects of bleomycin are marker-dependent.
• Results contrast with non-mutagenic findings in bacterial assays, suggesting differential mechanisms.